However, lower levels of predialytic PEDF have been found to be associated with an increased risk of mortality in HD patients, indicating that PEDF expression may be a response to the inflammatory and oxidative processes associated with CKD [20]. This evidence concerns the gene SERPINF1 and Huntington disease.